Cognition Therapeutics Inc (CGTX) Stock Price

1.11 ▲ +0.01 (+0.91%)
Open: 1.15 Vol: 1.02M Day's range: 1.09 - 1.17 Mar 25, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CGTX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.10▲ 1.11▼ 1.12▼ 1.10▲ 1.07▲
MA10 1.10▲ 1.12▼ 1.11▼ 1.10▲ 1.11▲
MA20 1.11▼ 1.11▼ 1.11▼ 1.09▲ 1.33▼
MA50 1.12▼ 1.11▼ 1.10▲ 1.16▼ 1.17▼
MA100 1.11▼ 1.10▲ 1.09▲ 1.36▼ 1.05▲
MA200 1.11▼ 1.09▲ 1.09▲ 1.32▼ 1.47▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ -0.002▼ -0.001▼ 0.010▲ -0.049▼
RSI 43.816▼ 45.224▼ 48.850▼ 50.071▲ 44.551▼
STOCH 25.556     12.451▼ 40.162     51.181     15.835▼
WILL %R -50.000     -81.250▼ -72.222     -38.889     -79.687▼
CCI -17.694     -160.520▼ -40.955     68.056     -45.391    
Latest Filters Detected On CGTX
▲ RSI&VOL $CGTX RSI Cross Up and Volume Set Alert
RSI $CGTX RSI(14) Crossed Above 50 Set Alert
MA $CGTX Price Crossed Above MA(7) Set Alert
▲ GAP $CGTX Open Gap Up %3 Set Alert
▲ GAP $CGTX Open Gap Up %2 Set Alert
Cognition Therapeutics Inc News
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update
Wednesday, March 25, 2026 05:00 PM
PURCHASE, N.Y., March 26, 2026 (GLOBE NEWSWIRE)-- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders, (the ...
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results
Monday, March 23, 2026 04:44 AM
Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders, (the “Company” or “Cognition”), plans to release financial ...
Cognition Therapeutics Presents Evidence of Zervimesine’s Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026
Tuesday, March 17, 2026 04:30 AM
Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented an analysis from the Phase 2 ...
CGTX historical stock data
date open high low close volume
25/03/26 1.15 1.17 1.09 1.11 1,017,719
24/03/26 1.13 1.14 1.07 1.10 499,033
23/03/26 1.08 1.1499 1.07 1.13 612,567
20/03/26 1.08 1.12 1.0501 1.07 636,471
19/03/26 1.10 1.12 1.03 1.08 827,337
18/03/26 1.14 1.15 1.09 1.10 893,803
17/03/26 1.10 1.1679 1.09 1.15 1,154,361
16/03/26 1.08 1.09 1.0401 1.08 447,275
13/03/26 1.10 1.11 1.045 1.05 405,379
12/03/26 1.12 1.14 1.0618 1.08 497,135
Quote Details
52wk Low:0.222
52wk High:3.83
Vol:1.02M
Avg Vol(3m):15.4M
1Y Chng:+247.53%
1M Chng:+0.91%
Add to Watch List
More Information
Index US Composite
Market Cap. 97.10M